Brief: Bellicum Pharmaceuticals posts Q4 net loss $19.9 mln
13/03/2017 20:05
March 13 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O
* Bellicum Pharmaceuticals provides operational update and
reports financial results for the fourth quarter and year ended
December 31, 2016
* Bellicum Pharmaceuticals Inc - Bellicum ended year on
December 31, 2016 with cash, restricted cash and investments
totaling $113.4 million
* Bellicum Pharmaceuticals Inc - expects that current cash
resources will be sufficient to meet operating requirements
through at least Q1 of 2018
* Bellicum Pharma- projected cash outlays in 2017 include
about $15 million for capital projects, primarily completion of
buildout of in-house facilities
* Bellicum Pharmaceuticals Inc - reported a net loss of
$19.9 million for Q4 of 2016
Source text for Eikon: ID:nGNXNQRYQa
Further company coverage: BLCM.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview